News and EVENTS
Quivive Partners with Camargo Pharmaceutical Services
Quivive Pharma Granted First US-PTO Patent
On July 3, 2018, US Patent No. 10,004,479 was allowed for the the combination of an opioid and a respiratory stimulant
On July 3, 2018, US Patent No. 10,004,479 was allowed for the the combination of an opioid and a respiratory stimulant